Catarina Vasco
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Catarina Vasco has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Ana C. Moreira
I3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
1 shared publicationAna G. Santos
I3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
1 shared publicationAna Rita Antunes
I3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
1 shared publicationAndreia Gonçalves
I3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
1 shared publicationBeatriz Porto
Laboratório de Citogenética, Instituto de Ciências Biomédicas Abel Salazar (ICBAS), Universidade do Porto, Porto, Portugal
1 shared publication- Cláudia Oliveira
Cytogenetics Laboratory, Department of Microscopy, ICBAS—School of Medicine and Biomedical Sciences, University of Porto, 4050-313 Porto, Portugal
1 shared publication
Latest Publications
- 19 October 2023
- Published by Springer Nature in Leukemia
- Vol. 38 (1) , 96-108
Iron overload induces dysplastic erythropoiesis and features of myelodysplasia in Nrf2-deficient mice
Iron overload (IOL) is hypothesized to contribute to dysplastic erythropoiesis. Several conditions, including myelodysplastic syndrome, thalassemia and sickle cell anemia, are characterized by ineffective erythropoiesis and IOL. Iron is pro-oxidant and may participate in the pathophysiology of these conditions by increasing genomic instability and altering the microenvironment. There is, however, lack of in vivo evidence demonstrating a role of IOL and oxidative damage in dysplastic erythropoiesis. NRF2 transcription factor is the master regulator of antioxidant defenses, playing a crucial role in the cellular response to IOL in the liver. Here, we crossed Nrf2−/− with hemochromatosis (Hfe−/−) or hepcidin-null (Hamp1−/−) mice. Double-knockout mice developed features of ineffective erythropoiesis and myelodysplasia including macrocytic anemia, splenomegaly, and accumulation of immature dysplastic bone marrow (BM) cells. BM cells from Nrf2/Hamp1−/− mice showed increased in vitro clonogenic potential and, upon serial transplantation, recipients disclosed cytopenias, despite normal engraftment, suggesting defective differentiation. Unstimulated karyotype analysis showed increased chromosome instability and aneuploidy in Nrf2/Hamp1−/− BM cells. In HFE-related hemochromatosis patients, NRF2 promoter SNP rs35652124 genotype TT (predicted to decrease NRF2 expression) associated with increased MCV, consistent with erythroid dysplasia. Our results suggest that IOL induces ineffective erythropoiesis and dysplastic hematologic features through oxidative damage in Nrf2-deficient cells.
- 19 October 2023
- Published by Springer Nature in Leukemia
- Vol. 38 (1) , 96-108
Iron overload induces dysplastic erythropoiesis and features of myelodysplasia in Nrf2-deficient mice
Iron overload (IOL) is hypothesized to contribute to dysplastic erythropoiesis. Several conditions, including myelodysplastic syndrome, thalassemia and sickle cell anemia, are characterized by ineffective erythropoiesis and IOL. Iron is pro-oxidant and may participate in the pathophysiology of these conditions by increasing genomic instability and altering the microenvironment. There is, however, lack of in vivo evidence demonstrating a role of IOL and oxidative damage in dysplastic erythropoiesis. NRF2 transcription factor is the master regulator of antioxidant defenses, playing a crucial role in the cellular response to IOL in the liver. Here, we crossed Nrf2−/− with hemochromatosis (Hfe−/−) or hepcidin-null (Hamp1−/−) mice. Double-knockout mice developed features of ineffective erythropoiesis and myelodysplasia including macrocytic anemia, splenomegaly, and accumulation of immature dysplastic bone marrow (BM) cells. BM cells from Nrf2/Hamp1−/− mice showed increased in vitro clonogenic potential and, upon serial transplantation, recipients disclosed cytopenias, despite normal engraftment, suggesting defective differentiation. Unstimulated karyotype analysis showed increased chromosome instability and aneuploidy in Nrf2/Hamp1−/− BM cells. In HFE-related hemochromatosis patients, NRF2 promoter SNP rs35652124 genotype TT (predicted to decrease NRF2 expression) associated with increased MCV, consistent with erythroid dysplasia. Our results suggest that IOL induces ineffective erythropoiesis and dysplastic hematologic features through oxidative damage in Nrf2-deficient cells.